Empagliflozin
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Neuropathy | 16% | x | ||
| Urinary tract infection | 7.6% - 9.3% | 7.6% | x | x |
| Retinal disorder | 8% | x | ||
| Diabetic nephropathy | 7% | x | ||
| Genital infection fungal | 1.6% - 6.4% | 0.4% - 1.5% | x | |
| Upper respiratory tract infection | 3.1% - 4% | 3.8% | x | |
| Dyslipidaemia | 2.9% - 3.9% | 3.4% | x | |
| Arthralgia | 2.3% - 2.4% | 2.2% | x | |
| Nausea | 1.1% - 2.3% | 1.4% | x | |
| Balanitis | x | |||
| Vaginal moniliasis | x | |||
| Infection | x | |||
| Cystitis | x | |||
| Dehydration | x | x | ||
| Diabetes mellitus | x | |||
| Diuresis | x | |||
| Dysuria | x | |||
| Hypotension | x | x | ||
| Orthostatic hypotension | x | x | ||
| Fungal infection | x | |||
| Nocturia | x | x | ||
| Tight foreskin | x | |||
| Polyuria | x | x | ||
| Pruritus | x | |||
| Syncope | x | x | ||
| Thirst | x | |||
| Pollakiuria | x | x | ||
| Urinary tract disorder | x | |||
| Angiopathy | x | |||
| Vulvitis | x | |||
| Vulvovaginitis | x | |||
| Polydipsia | x | |||
| Malnutrition | x | |||
| Haematocrit increased | x | |||
| Asymptomatic bacteriuria | x | |||
| Blood pressure systolic decreased | x | x | ||
| Vaginal infection | x | |||
| Hypovolaemia | x | x | ||
| Serum creatinine increased | x | |||
| Vulvovaginal candidiasis | x | |||
| Genital infection | x | x | ||
| Haematocrit decreased | x | |||
| Infestation NOS | x | |||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
